Helena Alvarez
Overview
Helena Alvarez helps clients meet their legal and business objectives by counseling them on Antitrust & Competition and Mass Tort, Product & Consumer Litigation matters.
Career & Education
- American University Washington College of Law, J.D., cum laude, 2023
- Georgetown University, B.S., Foreign Service, 2016
- District of Columbia
- Member, ABA Antitrust Law Section, 2024 – Present
- Member, ABA Tort Trial and Insurance Practice Section, 2024 – Present
- Member, ABA Young Lawyers Division, 2024 – Present
- Board Member and Fundraising Chair, Central American Resource Center (CARECEN), 2022 – Present
- English
- Spanish (native)
- French
Helena's Insights
Client Alert | 5 min read | 10.13.26
On October 1, 2026, Judge Brian M. Cogan of the U.S. District Court for the Eastern District of New York denied NYP’s motion to dismiss a consolidated antitrust complaint brought by three self-funded union health plans. The ruling is significant for two reasons. First, it demonstrates that plaintiffs can successfully allege market power against hospital systems even in the absence of traditionally high market shares. Second, the court’s reasoning closely tracks the arguments advanced by the DOJ in its Statement of Interest filed in the case: that market power need not be established through market share alone and can be shown through direct evidence such as supracompetitive pricing, and that exclusionary conduct and rival foreclosure are not required elements of a Section 1 claim. The recent decision validates the government’s legal theories and could enhance the viability of the DOJ’s parallel action against NYP, which is currently proceeding in the Southern District of New York.
Client Alert | 5 min read | 07.28.26
Data Centers in the Crosshairs: The Plaintiffs' Bar Has Begun Filing New Claims Using Old Tricks
Client Alert | 5 min read | 07.20.26
Client Alert | 5 min read | 05.18.26
The Hidden Ingredient Problem: PFAS Litigation and Regulation Are Reshaping the Beauty Industry
Insights
Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA
|04.08.26
Crowell & Moring’s Retail & Consumer Products Law Observer
- |
09.08.25
Crowell & Moring’s Transportation Law: Moving Forward
- |
08.28.25
Crowell & Moring’s Retail & Consumer Products Law Observer
- |
06.20.25
Crowell & Moring’s Retail & Consumer Products Law Observer
MoCRA Under the Trump Era: A Look at FDA’s Monitoring and Enforcement Two Months In
|03.27.25
Crowell & Moring’s State AG Blog
CPSC Announces New Staff Appointments
|03.14.25
Crowell & Moring’s Retail & Consumer Products Law Observer
What’s In and What’s Out? Cosmetic Companies Face Ingredient Compliance Conundrum
|01.17.24
Crowell & Moring’s Retail & Consumer Products Law Observer
CPSC Publishes Report on Artificial Intelligence and Machine Learning
|06.03.21
Crowell & Moring’s Retail & Consumer Products Law Observer
Helena's Insights
Client Alert | 5 min read | 10.13.26
On October 1, 2026, Judge Brian M. Cogan of the U.S. District Court for the Eastern District of New York denied NYP’s motion to dismiss a consolidated antitrust complaint brought by three self-funded union health plans. The ruling is significant for two reasons. First, it demonstrates that plaintiffs can successfully allege market power against hospital systems even in the absence of traditionally high market shares. Second, the court’s reasoning closely tracks the arguments advanced by the DOJ in its Statement of Interest filed in the case: that market power need not be established through market share alone and can be shown through direct evidence such as supracompetitive pricing, and that exclusionary conduct and rival foreclosure are not required elements of a Section 1 claim. The recent decision validates the government’s legal theories and could enhance the viability of the DOJ’s parallel action against NYP, which is currently proceeding in the Southern District of New York.
Client Alert | 5 min read | 07.28.26
Data Centers in the Crosshairs: The Plaintiffs' Bar Has Begun Filing New Claims Using Old Tricks
Client Alert | 5 min read | 07.20.26
Client Alert | 5 min read | 05.18.26
The Hidden Ingredient Problem: PFAS Litigation and Regulation Are Reshaping the Beauty Industry




